Stock Pick - MNKD

Question

.......biotech.....I&#x27;m invested pretty big here........recently submitted to FDA approval, expected notification on approval April 2014.........see where this one is at come June/July next year....High risk,  high reward.Drug treats diabetes as well as provides ease of use in how a diabetec intakes AFREZZA (insulin) via an easy to use/discreet inhaler through lungs.Fast acting insulin.     or   Only time will tell....

Louis_IV · Answer

.......biotech.....I&#x27;m invested pretty big here........recently submitted to FDA approval, expected notification on approval April 2014.........see where this one is at come June/July next year....High risk,  high reward.Drug treats diabetes as well as provides ease of use in how a diabetec intakes AFREZZA (insulin) via an easy to use/discreet inhaler through lungs.Fast acting insulin.     or   Only time will tell....

Louis_IV · Answer

As of this post $5 a share....

avenue · Answer

BOL

Rush51 · Answer

[Quote: Originally Posted by Louis_IV] .......biotech.....&#xD;&#xA;&#xD;&#xA;&#xD;&#xA;I&#x27;m invested pretty big here....&#xD;&#xA;&#xD;&#xA;....recently submitted to FDA approval, expected notification on approval April 2014....&#xD;&#xA;&#xD;&#xA;.....see where this one is at come June/July next year....&#xD;&#xA;&#xD;&#xA;High risk,  high reward.&#xD;&#xA;&#xD;&#xA;Drug treats diabetes as well as provides ease of use in how a diabetec intakes AFREZZA (insulin) via an easy to use/discreet inhaler through lungs.&#xD;&#xA;&#xD;&#xA;Fast acting insulin.&#xD;&#xA;&#xD;&#xA;     or   &#xD;&#xA;&#xD;&#xA;Only time will tell....&#xD;&#xA;[/Quote]&#xD;&#xA; &#xD;&#xA;Well, you hit it on the head.  High Risk, High Reward. &#xD;&#xA;Like any Biotech or Pharma co. , your fortunes ride on the blessing on the FDA. &#xD;&#xA;Never forget this.

Lucrative · Answer

I jumped in for a dabble

Louis_IV · Answer

[Quote: Originally Posted by Rush51]  &#xD;&#xA; &#xD;&#xA;Well, you hit it on the head.  High Risk, High Reward. &#xD;&#xA;Like any Biotech or Pharma co. , your fortunes ride on the blessing on the FDA. &#xD;&#xA;Never forget this.    [/Quote]Yep, it will be a big blow if I lose this one but I&#x27;m a believer, I just hope the FDA as corrupt as they are, do the right thing and approve this one.

Louis_IV · Answer

Hope we cash, good luck

Louis_IV · Answer

$4.89 as of today..........slightly lower

Rush51 · Answer

BOL to you...

Louis_IV · Answer

thanks Rush, I&#x27;m sure dealing with the FDA, luck will come in handy.  Maybe a little bribery as well.

Louis_IV · Answer

12/27 close, $5.20.  Up a few centsAverage buy-in was $4.90.

duong02743 · Answer

I wished I read this thread two week ago. This stock jumps over 20% today 1/9/14.  I am not sure they still keep jumping .Any info?

rubberneck · Answer

I did not buy any but if anyone did @ $5 it&#x27;s about time to take profits

Lucrative · Answer

Bought at 5.05 on 11/18. Nice jump yesterday; it is back down some today.Louis what do think the ceiling is for this one? I assume you are holding until the FDA reports next month?

Lucrative · Answer

FYI:VALENCIA, Calif., Jan. 10, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD)&#xD;&#xA; today announced that the Endocrinologic and Metabolic Drugs Advisory &#xD;&#xA;Committee of the U.S. Food and Drug Administration (FDA) is tentatively &#xD;&#xA;scheduled on April 1, 2014 to review MannKind&#x27;s New Drug Application &#xD;&#xA;(NDA) for AFREZZA(R) &#xD;&#xA;(insulin human [rDNA origin]) Inhalation Powder. The date and details of&#xD;&#xA; the meeting are subject to confirmation by the FDA in a Federal &#xD;&#xA;Register notice. MannKind resubmitted the NDA on October 13, 2013 &#xD;&#xA;seeking approval to market AFREZZA in the United States with an &#xD;&#xA;indication to improve glycemic control in adults with type 1 or type 2 &#xD;&#xA;diabetes. The target date for the FDA to complete its review of the &#xD;&#xA;AFREZZA NDA is April 15, 2014.

duong02743 · Answer

I see, that&#x27;s why they are dropping big time today -

JEFFMARKETCAP · Answer

Can&#x27;t believe that such a drop is warranted by this news.  I made a lot of money on some MNKD calls.  Thank God I sold for a quick profit.  I still love the stock.  Could be a big winner.  It should run up ahead of the April 1st date.

Louis_IV · Answer

I made some coin on a sale earlier this month.  I&#x27;m LONG though with half of it.  Its a steal at these prices right now in my view.  As I said before, its high risk high reward.  At the time of this post its trading at $5.55 a share.  I&#x27;ll be accumulating my position here and even more so on any dips.  I want to get back to where I was before my last sale.  I knew it would drop in the near term off the $7 in early January, still made some nice money.  This stock is by far my largest position in my portfolio at this time, was more so prior to the recent sale, as I said I am getting reestablished again.

Louis_IV · Answer

Ceiling, wow, hard to say.  Do some research on the CEO if you have not already. Billionaire!  Genius! Many, many past successes in Boitech, and has a passion for this, has invested billions of his own money.  So, ceiling, man, it could be really big.  I&#x27;m hoping for a partner here in the next month to be announced.  The key is the approval though.  No reason this should not get approved unless there is corruption in the FDA as it relates to this drug.  They should have been approved last time but a change in the delivery system during testing required additional analysis.  That&#x27;s it.  Drug was fine.

Louis_IV · Answer

just added some more at 5.25.........still have some powder if it drops more in short term.

Lucrative · Answer

Indeed. I have looked into it. For a biotech venture capitalist to invest over 900 million into his own company speaks volumes. He&#x27;s either crazy, or onto the next big thing.The application would be revolutionary in the diabetes market. Anyway, win or lose it&#x27;s an interesting prospect. I plan on being in for the long run

lsharks · Answer

The key is approval AND getting word out to the Medical World who can advise Diabetics to use it...  I am in for the long run also.

Louis_IV · Answer

if it gets approved, which it should and docs don&#x27;t advise people to use it, in my view, they are not doing their jobs.  There is nothing out there like this that could prevent diabetics from dying unnecessarily.  That said, doctors don&#x27;t always care to do what is right.  My wife works with them daily and knows that not all are motivated to do "what is the best" for the patient.  Marketing will need to be high, I would expect that from MNKD partner.

lsharks · Answer

Strong Marketing are the words I was looking for and I would expect it also from MNKD. Another Insulin company called ORMP may affect MNKD. If ORMP Oral Insulin gets approved, I don't think the diabetics would go for the inhaler. Just sayin...

Louis_IV · Answer

I think ORMP is a ways away and I believe what gets treated and how are two different things, not apples to apples.ORMP is not a threat to MNKD&#x27;s Afreeza for quite some time if at all. They have yet to begin FDA 3 and Afreeza is more than just an inhaler. Its patented insulin is "prandial" meaning it mimics the natural insulin faster and more like the human pancreas. The "dreamboat" less than palm size inhaler can be adapted to many other drug delivery systems.Afreeza is ready to go and anxiously awaited by those that were trial subjects and was almost approved before except for a request to test their newly introduced tiny inhaler which was done with FDA cooperation. Finally this market is huge and various combinations of treatments will be worked out between Doctor and patient. As with asthmatics many patients will no doubt become comfortable with the inhaler long before ORMP&#x27;s drug hits the market and will stick with it&#x27;s convenience and fast action.

Stock Pick - MNKD

Hot Forum Topics